Locations:
Min Investment:
Max Investment:
Target Investment:
(2004 - 2008)
Total Funding: $170M
Total Funding: $290M
Total Funding: $220M
Total Funding: $270M
Total Funding: $250M
Total Funding: $90M
Total Funding: $83M
Total Funding: $77M
Total Funding: $140M
Total Funding: $180M
Total Funding: $200M
2020
2013 - 2020
2017 - 2020
2015 - 2017
2013 - 2015
2008 - 2013
- Developed and optimized a novel biological adhesive hydrogel for meniscal and cartilage tissue repair - Evaluated the potential of biologic hydrogels to regenerate bone and cartilage in a pre-clinical large animal model as a critical step to seeking funding for clinical translation - Collaborated with clinicians to develop endoscopic delivery protocol of a tissue adhesive to prevent scarring in gastroenterological and otolaryngological applications - Mentored seven undergraduate or visiting students in biomaterial development and regenerative medicine techniques
2010 - 2010
2010 - 2010
Developed a fully biologic hydrogel carrier to deliver and localize recombinant human bone morphogenetic protein-2 to enhance musculoskeletal tissue repair
2009 - 2009
2009 - 2009
Provided technical support for data collection and analysis leading to approval of ChondroCelect®, the first cell therapy approved by the European Medicines Agency
2006 - 2008
2006 - 2008
- Identified and analyzed the distribution of lubricin in samples of human intervertebral disc using immunohistochemistry techniques to determine the source and role of this protein in disc function - Synthesized and characterized collagen-GAG hybrid scaffolds for use in nucleus pulposus regeneration using human mesenchymal stem cells